Is Epigenomics AG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Epigenomics AG pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 16th of September 2021 were paid $0.1186 per share. Over the last 5 times between 2018 and 2021, Epigenomics AG has paid $5.7982 with an average of $1.16 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Epigenomics AG 10 years ago, but if you had invested on Tuesday 4th of January 2022 when the price was $3.57, you would have made a loss of $-1.180 per share or -33.05%
No, the average daily trading liquidity for Epigenomics AG is $9 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Epigenomics AG has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Epigenomics AG to be medium [0.7 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.